Although meta-analysis of the literature indicated that serum GPC3 is higher in HCC patients than normal subjects, the reported values differed considerably between the studies, probably due to different antibody epitopes in each ELISA setting and heterogeneity of molecular forms of serum GPC3 [83,85,86]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.